Make short and crisp notes with relevant points on flowcytometry and multiplex pcr for md dermatology exam… make it highly relevant to the md dermatology exam
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Flow Cytometry & Multiplex PCR — MD Dermatology Exam Notes
1. FLOW CYTOMETRY
Principle
- Cells in suspension (blood/tissue digest), pre-labeled with fluorochrome-conjugated antibodies, pass single-file through a laser beam.
- Detectors measure fluorescence intensity (antigen expression) and light scatter (cell size/granularity) simultaneously on thousands of cells.
- FACS (fluorescence-activated cell sorting) variant can physically sort/separate labeled cell populations into different tubes. (Dermatology 2-Volume Set 5e, p. 79)
Key exam application: Sézary syndrome (SS) / erythrodermic CTCL
-
Diagnostic blood criteria (high-yield, often asked as MCQ):
- Absolute Sézary cell count ≥1000 cells/mm³
- CD4/CD8 ratio ≥10 on flow cytometry (due to expanded clonal CD4+ population)
- Aberrant immunophenotype: expanded CD4+CD8- population; loss of CD7 and/or CD26 on CD4+ T cells (CD4+CD7- or CD4+CD26- clones)
- Demonstration of a T-cell clone (by TCR gene rearrangement, see below) supports diagnosis (Andrews' Diseases of the Skin, p. affected; Fitzpatrick's Dermatology - Laboratory Findings/Pathology sections)
-
Blood staging (B classification) in mycosis fungoides/SS (ISCL/EORTC) — uses flow cytometry:
- B0: no significant blood involvement
- B1: low blood tumor burden (does not meet B2)
- B2: high blood tumor burden = Sézary cell criteria met (as above)
- Note: erythrodermic MF can show identical T-cell clone in skin and blood but normal/low-level flow cytometry (B0/B1) — distinguishes it from Sézary syndrome. (Dermatology 2-Volume Set, p. 2610-2612)
-
Other CTCL immunophenotype pearls:
- Clonal cells typically CD3+, CD4+, CD8-
- Aberrant loss of pan-T markers (CD2, CD3, CD4, CD5, CD7) is a marker of malignancy
- Used for minimal residual disease monitoring and treatment response
Other dermatology-relevant uses (for completeness in exam context)
- Workup of suspected cutaneous lymphoma (B-cell or T-cell) when nodal/systemic disease suspected — immunophenotyping of peripheral blood or fine-needle aspirate
- Differentiating reactive erythroderma from leukemic/lymphomatous erythroderma
- Ancillary to serum LDH, peripheral smear, and TCR-PCR in staging workup of MF/SS
Exam pearls
- Remember: flow cytometry = quantitative immunophenotyping of blood/fresh tissue, complements but does not replace skin biopsy + IHC.
- CD4/CD8 ratio >10 is the single most quoted cut-off — favorite MCQ stem.
- Requires fresh tissue/blood (not formalin-fixed) — a commonly tested limitation.
2. MULTIPLEX PCR
Principle
- Single PCR reaction using multiple primer pairs simultaneously to amplify several different DNA/RNA targets in one tube — saves time, sample, and cost versus running separate single-target PCRs.
High-yield dermatology applications
| Clinical scenario | Multiplex PCR panel |
|---|---|
| Genital ulcer disease (GUD) | HSV-1/2 + Treponema pallidum + Haemophilus ducreyi (chancroid) — differentiates herpetic, syphilitic, chancroidal ulcers when clinical/serologic overlap exists |
| Vesiculobullous/vesicular eruptions (e.g., suspected herpes zoster/varicella vs HSV) | HSV-1, HSV-2, VZV (+/- enterovirus) multiplex PCR from vesicle fluid/swab — now largely replaced Tzanck smear and DFA as gold standard because of higher sensitivity and rapid turnaround (Fitzpatrick's Dermatology - Diagnosis/Laboratory Diagnosis) |
| Suspected CNS/disseminated HSV-VZV | CSF multiplex PCR panels (HSV-1/2, VZV, enterovirus, HHV-6) |
| Onychomycosis / tinea | Dermatophyte-specific multiplex PCR for species identification (Trichophyton, Microsporum, Epidermophyton) — faster than culture, useful when KOH is positive but culture is negative/slow |
| Cutaneous leishmaniasis | Species-specific multiplex PCR from skin scraping/biopsy — important for treatment choice (New World vs Old World species) |
| Cutaneous TB / leprosy | Mycobacterial PCR panels for rapid speciation in paucibacillary disease where AFB smear is often negative |
| Brucella/other zoonotic ulcers (occasionally asked) | Multiplex PCR for Brucella DNA in atypical skin/systemic presentations |
Related but distinct — TCR gene rearrangement PCR (clonality assay)
- Not strictly "multiplex" in the infectious-disease sense, but a PCR-based molecular test heavily tested in dermatology exams alongside flow cytometry for CTCL/mycosis fungoides workup.
- Detects a dominant clonal T-cell population by amplifying variable regions of the TCR gene (V, D, J segment rearrangements) — analogous rearrangement occurs in immunoglobulin genes for B-cell clonality.
- Used to:
- Support diagnosis of early MF when histology is equivocal
- Confirm identical clone in skin and blood (staging Sézary syndrome vs erythrodermic MF)
- Detect minimal residual disease (Dermatology 2-Volume Set, "Immunoglobulins"/TCR gene rearrangement, p. 241-251)
Advantages of multiplex PCR (exam bullet points)
- Rapid (hours vs days for culture)
- High sensitivity and specificity, detects low pathogen load
- Single sample, single run for multiple pathogens — cost- and time-efficient
- Can distinguish closely related pathogens/strains (e.g., HSV vs VZV, wild-type VZV vs Oka vaccine strain)
Limitations (commonly asked)
- Cannot always distinguish colonization/carriage from true infection
- Requires quality nucleic acid extraction; contamination risk with false positives
- Higher cost of multiplex assay/equipment versus single-target PCR
- Does not provide antimicrobial susceptibility (unlike culture)
Quick comparison table for exam recall
| Feature | Flow Cytometry | Multiplex PCR |
|---|---|---|
| Detects | Cell surface/intracellular antigens (protein) | Nucleic acid (DNA/RNA) of multiple targets |
| Sample | Fresh blood/tissue suspension | Blood, swab, tissue, CSF |
| Classic derm use | Sézary syndrome diagnosis/staging, CTCL immunophenotyping | Genital ulcer panel, HSV/VZV vesicle panel, dermatophyte ID, leishmania speciation |
| Key numeric cutoff to remember | CD4/CD8 ratio ≥10, Sézary cells ≥1000/mm³ | N/A (qualitative/quantitative detection) |
| Limitation | Needs fresh sample, cannot be done on fixed tissue | Colonization vs infection distinction, cost |
These two points (Sézary flow criteria + HSV/VZV or GUD multiplex PCR) are the most frequently recurring exam-relevant facts — memorize the CD4/CD8 ratio ≥10 and Sézary cell count ≥1000/mm³ criteria verbatim, as they are asked as direct one-liners in MD Dermatology theory and viva.
Retry
Flow Cytometry & Multiplex PCR — MD Dermatology Exam Notes
1. FLOW CYTOMETRY
Principle
- Fluorochrome-labeled cells in suspension pass single-file through a laser; detectors read fluorescence (antigen expression) + light scatter (size/granularity).
- FACS variant physically sorts labeled populations.
- Requires fresh blood/tissue (not formalin-fixed) — classic limitation asked in exams.
Key application: Sézary syndrome (SS) diagnosis — HIGH YIELD
- Absolute Sézary cell count ≥1000 cells/mm³
- CD4/CD8 ratio ≥10
- Aberrant CD4+CD8- clonal population with loss of CD7 and/or CD26
- Supported by demonstrating a T-cell clone (TCR-PCR, see below)
Blood staging (B classification) in MF/SS (ISCL/EORTC) — uses flow cytometry
- B0 = no significant blood involvement
- B1 = low tumor burden (doesn't meet B2)
- B2 = high tumor burden = meets Sézary criteria above
- Erythrodermic MF can share an identical skin-blood T-cell clone but flow cytometry is normal/low (B0-B1) — this is the key point distinguishing it from true Sézary syndrome.
Other CTCL immunophenotype pearls
- Malignant clone: CD3+ CD4+ CD8-, with aberrant loss of pan-T markers (CD2, CD3, CD4, CD5, CD7)
- Used for staging, monitoring minimal residual disease, and treatment response
2. MULTIPLEX PCR
Principle
- One reaction, multiple primer pairs → simultaneous amplification/detection of several targets — faster and cheaper than serial single-target PCRs.
High-yield dermatology applications
| Scenario | Panel |
|---|---|
| Genital ulcer disease | HSV-1/2 + T. pallidum + H. ducreyi (differentiates herpetic/syphilitic/chancroidal ulcers) |
| Vesiculobullous lesion (suspected herpes) | HSV-1, HSV-2, VZV (± enterovirus) from vesicle swab — now largely replaces Tzanck smear/DFA as gold standard (higher sensitivity, rapid) |
| CNS/disseminated disease | CSF panel: HSV-1/2, VZV, enterovirus, HHV-6 |
| Onychomycosis/tinea | Dermatophyte species-ID PCR — faster than culture when KOH+/culture negative or slow |
| Cutaneous leishmaniasis | Species-specific PCR — guides treatment (Old World vs New World) |
| Cutaneous TB/leprosy | Mycobacterial PCR — useful when AFB smear negative (paucibacillary disease) |
Related PCR test heavily co-tested with flow cytometry: TCR gene rearrangement (clonality) PCR
- Detects a dominant T-cell clone by amplifying variable (V-D-J) regions of the TCR gene.
- Uses in CTCL: supports diagnosis in early/equivocal MF, confirms identical clone in skin + blood (SS vs erythrodermic MF), detects minimal residual disease.
Advantages
- Rapid, highly sensitive/specific, single sample for multiple pathogens, can distinguish closely related agents (e.g., wild-type VZV vs Oka vaccine strain).
Limitations
- Can't reliably separate colonization from true infection
- Contamination risk → false positives
- No antimicrobial susceptibility data (unlike culture)
- Costlier equipment/assay than single-target PCR
Exam quick-recall table
| Feature | Flow Cytometry | Multiplex PCR |
|---|---|---|
| Detects | Surface/intracellular antigens (protein) | Nucleic acid (multiple targets at once) |
| Sample | Fresh blood/tissue | Swab, blood, tissue, CSF |
| Classic derm use | Sézary syndrome dx/staging | GUD panel, HSV/VZV vesicle panel, dermatophyte/leishmania ID |
| Numeric cutoff to memorize | CD4/CD8 ≥10, Sézary cells ≥1000/mm³ | — |
| Key limitation | Needs fresh, unfixed sample | Colonization vs infection ambiguity |
Must-memorize one-liners for viva/theory: CD4/CD8 ratio ≥10 and Sézary cell count ≥1000/mm³ define Sézary syndrome on flow cytometry; multiplex PCR is now first-line for HSV/VZV vesicle diagnosis, replacing Tzanck smear.
This is a shared conversation. Sign in to Orris to start your own chat.